Maximum Loperamide Dosing
For adults, the maximum dose of loperamide (Imodium) is 16 mg per day (8 capsules), and for children aged 2–12 years, the maximum varies by age and weight: 3 mg/day for ages 2-5 years (13-20 kg), 4 mg/day for ages 6-8 years (20-30 kg), and 6 mg/day for ages 8-12 years (>30 kg). 1
Adult Dosing
The FDA-approved dosing regimen for adults is straightforward:
- Initial dose: 4 mg (two 2 mg capsules) at onset of diarrhea
- Maintenance: 2 mg after each unformed stool
- Maximum daily limit: 16 mg (8 capsules) in 24 hours 1
This dosing is consistently supported across multiple clinical guidelines for travelers' diarrhea 2, chemotherapy-induced diarrhea 3, 4, 3, and radiation-induced diarrhea 3. The 16 mg/day ceiling should not be exceeded in routine clinical practice.
Pediatric Dosing (Ages 2-12 Years)
Loperamide is contraindicated in children under 2 years of age due to risk of serious adverse effects including paralytic ileus and central nervous system toxicity from immature hepatic function and blood-brain barrier 2, 1.
For children 2-12 years, dosing is weight and age-based 1:
First day dosing:
- Ages 2-5 years (13-20 kg): 1 mg three times daily (3 mg total daily dose)
- Ages 6-8 years (20-30 kg): 2 mg twice daily (4 mg total daily dose)
- Ages 8-12 years (>30 kg): 2 mg three times daily (6 mg total daily dose)
Subsequent days: 1 mg per 10 kg body weight after each loose stool, not exceeding the first-day maximum for that age group 1
The liquid formulation (1 mg/7.5 mL) should be used for children 2-5 years; either capsules or liquid may be used for ages 6-12 1.
Critical Safety Considerations
Avoid loperamide entirely in:
- Dysentery (bloody diarrhea with fever) 2, 5
- Suspected invasive pathogens (Campylobacter, Salmonella, Shigella) 2
- Children under 18 years per some guidelines 5, though FDA labeling permits use ≥2 years with appropriate dosing 1
Cardiac toxicity warning: While rare at therapeutic doses, loperamide can cause QT prolongation, torsades de pointes, and cardiac arrest when taken in massive overdoses (64-1600 mg/day) 6, 7, 8, 9. At recommended doses for chemotherapy-induced diarrhea, the cardiac risk remains extremely low and is outweighed by benefits of controlling severe diarrhea 6.
Duration limits: Clinical improvement should occur within 48 hours 1. If diarrhea persists beyond 48 hours on loperamide, escalate to second-line therapy (octreotide) and evaluate for infectious or complicated causes 4.
Practical Algorithm
- Confirm no contraindications (age <2 years, dysentery, invasive pathogen suspected)
- Start appropriate dose based on age/weight
- Monitor response at 24-48 hours
- Discontinue 12 hours after last unformed stool (chemotherapy-induced) or continue through radiation therapy course (radiation-induced) 4
- Escalate care if no improvement by 48 hours or if complications develop (fever, severe cramping, dehydration)
The evidence consistently supports these maximum daily limits across all clinical contexts, with the FDA drug label 1 serving as the definitive dosing authority.